12:29 CET
301 - CME 2 - Oncology & Theranostics Committee: NET - PRRT and More
Sunday, October 13, 11:30 - 13:00
Room: Auditorium
Type of session: CME Session
Chairpersons: I. Virgolini (Vienna/AT), V. Ambrosini (Bologna/IT)

OP-071
11:30
PET/CT Imaging of PPGL in the Era of Genomic Disease Characterization (EANM/SNMMI 2019 Guidelines)
D. Taïeb;
Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, FRANCE.
OP-072
11:50
Long-Term Outcome of PRRT and Predictors of Outcome
M. Gabriel;
Allgemeines Krankenhaus Linz, Institut für Nuklearmedizin und Endokrinologie, Linz, AUSTRIA.
OP-073a
12:10
PRRT - Individualized Dosimetry vs. Fixed Dose Scheme
A. Haug;
University Clinic of Nuclear Medicine, Medical University of Vienna, Vienna, AUSTRIA.
OP-073b
12:35
PRRT Treatment Sequencing and Combinations
R. Hicks;
Department of Nuclear Medicine and PET, Peter MacCallum Cancer Institute, Melbourne, AUSTRALIA.
This website uses cookies. Learn more